Jayamas Medica Industri

Jayamas Medica Industri

OMED · JK · Healthcare / Medical Instruments & Supplies

179.00IDR+9.00 (+5.29%)

Price History

Full chart

Market Stats

Previous Close170.00
Open170.00
Day Range169.00 – 180.00
52-Week Range176.43 – 311.70
Volume2.05M
Market Cap5.73T
P/E (TTM)13.37
Forward P/E11.76
EPS15.86
Dividend Yield1.91%
Beta0.10
50-Day Avg223.00
200-Day Avg229.45

About

PT Jayamas Medica Industri Tbk manufactures and sells medical devices in Indonesia, the United States of America, and South America. The company operates through three segments: Manufacturing, Distribution, and Retail. It offers medical disposables and consumables comprising medical gloves, syringes, masks, gauze, bandages, urine bag, foley catheter, alcoholic tissue, etc.; antiseptic and disinfectant fluids, povidone iodine, medical alcohol, Hdsol or blood cleansing liquid, etc.; and diagnostics and equipment, such as patient monitor, vital signs monitor, ECG reader, syringe pump, infusion pump, blood pressure monitors, oximeter, fingertip pulse oximeters etc. The company also provides walking aids and rehabilitation care products, including wheelchairs, crutches, walkers, arm slings etc.; biotechnology and laboratory products, such as pregnancy test, PCR test, blood collection tube, PCT tube, chemical reagents, etc; and hospital furniture products comprising patient bed, bed side cabinet, children's patient bed, and operation lamp, as well as wound care products which include plasters, cotton, sterile gauze, etc. In addition, the company engages in warehousing and storage activities; and engages in the manufacturing, selling, and repairs and maintenance of medical devices. It retails medical supplies and equipment through Medicom stores and online platforms. PT Jayamas Medica Industri Tbk was founded in 2000 and is headquartered in Sidoarjo, Indonesia. PT Jayamas Medica Industri Tbk operates as a subsidiary of Pt. Intisumber Hasilsempurna.

Company Details

  • SectorHealthcare
  • IndustryMedical Instruments & Supplies
  • CEODr. Herlien Sri Ariani
  • Employees1.34K
  • HeadquartersJl. Bypass Krian RT 05/RW 01, Sidoarjo, Indonesia, 61262, Indonesia
  • Websitehttps://www.onemed.co.id

Leadership

  • Dr. Herlien Sri ArianiPresident Director · b. 1965
  • Mr. Eka SuwignyooDirector of Finance & Director · b. 1980
  • Mr. Leonard Hariadi HartantoDirector of Operations & Director · b. 1991
  • Mr. Louis Krisnadi HartantoMarketing & Sales Director and Director · b. 1993
  • Mr. Daniel KurniawanCorporate Secretary · b. 1984

Financials

Income Statement

Currency: IDR2019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue1.23T1.99T2.23T1.74T1.74T1.89T2.06T
Growth (%)-+62.42%+11.63%-21.90%-0.12%+8.57%+9.44%
Cost of Revenue782.58B957.60B1.32T1.18T1.18T1.26T1.37T
Gross Profit445.47B1.04T904.29B563.07B552.00B623.98B695.09B
Gross Margin36.27%51.99%40.61%32.38%31.78%33.09%33.68%
Operating Expense442.14B182.73B169.83B184.13B249.44B275.50B308.72B
Operating Income3.33B854.21B734.46B378.95B302.56B348.47B386.38B
Operating Margin0.27%42.83%32.99%21.79%17.42%18.48%18.72%
EBITDA305.79B872.22B768.20B415.70B370.67B433.68B457.37B
EBITDA Margin24.90%43.73%34.50%23.90%21.34%23.00%22.16%
Net Income226.21B685.51B562.69B285.78B259.36B321.67B366.95B
Net Income Margin18.42%34.37%25.27%16.43%14.93%17.06%17.78%
R&D514.70M715.10M-----
R&D as % of Total Revenue0.04%0.04%-----
Interest Expense531.56M9.01B21.71B20.65B19.41B19.58B17.88B
Interest Expense % of Total Revenue0.04%0.45%0.97%1.19%1.12%1.04%0.87%

Balance Sheet

Currency: IDR2019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets662.07B1.42T1.73T2.51T2.58T2.83T3.20T
Total Liabilities476.85M466.01B480.96B437.90B336.07B329.64B445.08B
Total Equity561.41B938.86B1.22T2.04T2.22T2.46T2.72T
Cash316.21B697.03B732.84B830.55B1.12T1.22T1.28T
Total Debt2.27B165.33B186.67B199.70B189.23B185.53B216.11B
Net Debt-313.94B-531.70B-546.18B-630.85B-931.34B-1.04T-1.06T

Cash Flow

Currency: IDR2019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow174.72B278.73B505.11B92.62B134.35B351.57B395.08B
Investing Cash Flow-15.07B-49.84B-187.06B-495.10B264.59B-164.15B-229.08B
Financing Cash Flow-1.69B150.83B-282.97B493.49B-110.58B-95.19B-95.40B
Capital Expenditure14.49B52.45B82.78B75.37B156.39B102.34B115.89B
Free Cash Flow160.22B226.29B422.32B17.25B-22.09B249.23B279.19B
Dividends Paid00255.00B250.00B85.78B77.93B96.55B
FCF to OCF91.70%81.18%83.61%18.62%-16.44%70.89%70.67%
Dividend Paid to FCF0.00%0.00%60.38%1449.55%-388.35%31.27%34.58%

Earnings

Report DateMay 31, 2023
EPS Estimate-
EPS Actual2.45
Surprise-
TimingAfter-hours

Key Statistics & Ratios

Market Cap5.73T
Enterprise Value4.41T
Trailing P/E13.37
Forward P/E11.76
Price / Sales2.48
Price / Book1.97
EPS15.86
Book Value104.76
Revenue (TTM)2.30T
Gross Profit (TTM)823.81B
EBITDA515.39B
Profit Margin18.77%
Operating Margin19.91%
Return on Equity16.10%
Return on Assets9.17%
Shares Outstanding27.01B
Shares Float3.95B
Beta0.10
Dividend Yield1.91%
Dividend Rate4.08
Payout Ratio47.78%

Dividends

20261×
4.08Jun 18, 2026
20251×
3.57Jul 8, 2025
20241×
2.88Jun 20, 2024
20231×
3.17Jun 7, 2023